GoAI
Get started
StemCell Institute Inc. logo

StemCell Institute Inc.

7096.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥767

−¥8.00 · -1.03%

Aug 24, 3:30 PM JST

7096.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

StemCell Institute Inc. provides specialized stem cell banking services throughout Japan. In addition to its core preservation activities, the company is deeply involved in the research and development of medical therapies that utilize stem cells, and it also offers banking solutions for blood vessel cells. Founded in 1999, StemCell Institute Inc. is headquartered in Tokyo, Japan, and operates as a subsidiary of Trim Medical Holdings Inc.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Takafumi Shimizu
Listed since
Jun 25, 2021
Employees
117

Market position

Day range

Current ¥767

52-week range

Current ¥767

Open
¥772
Previous close
¥775
Volume
2.1K
0.23× average
Average volume
9.18K
Average daily volume
Market cap
7.72B JPY
Beta
0.59
Market reference 1
50-day average
¥728.54
+5.28% above average
200-day average
¥768.28
-0.17% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.38B JPY
P/E (TTM)
52.64×
P/B (TTM)
2.84×
P/S (TTM)
2.73×
EV / EBITDA
14.15×
Earnings yield
2.02%
Free cash flow yield
-4.34%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
60.14%
Operating margin
6.30%
Net margin
5.18%
Return on equity
5.81%
Return on assets
1.92%
Return on invested capital
3.33%

Financial health

Debt / equity
0.23×
Current ratio
1.17×
Altman Z-score
1.68
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends70%46%23%-0%Gross margin, FY2021: 62.36%Gross margin, FY2022: 63.88%Gross margin, FY2023: 63.51%Gross margin, FY2024: 63.16%Gross margin, FY2025: 60.90%Operating margin, FY2021: 12.74%Operating margin, FY2022: 14.23%Operating margin, FY2023: 16.68%Operating margin, FY2024: 15.62%Operating margin, FY2025: 7.21%Net margin, FY2021: 7.50%Net margin, FY2022: 9.47%Net margin, FY2023: 12.53%Net margin, FY2024: 14.40%Net margin, FY2025: 5.55%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 62.36%. Gross margin FY2022 63.88%. Gross margin FY2023 63.51%. Gross margin FY2024 63.16%. Gross margin FY2025 60.90%. Operating margin FY2021 12.74%. Operating margin FY2022 14.23%. Operating margin FY2023 16.68%. Operating margin FY2024 15.62%. Operating margin FY2025 7.21%. Net margin FY2021 7.50%. Net margin FY2022 9.47%. Net margin FY2023 12.53%. Net margin FY2024 14.40%. Net margin FY2025 5.55%.

Income trends

Revenue

2.81B JPY+4.93%

Operating income

202.66M JPY-51.58%

Net income

155.92M JPY-59.59%
Income trends across reported periods3.08B JPY2.01B JPY937.01M JPY−134.04M JPYRevenue, FY2021: 1.78B JPYRevenue, FY2022: 2.09B JPYRevenue, FY2023: 2.48B JPYRevenue, FY2024: 2.68B JPYRevenue, FY2025: 2.81B JPYOperating income, FY2021: 226.95M JPYOperating income, FY2022: 297.56M JPYOperating income, FY2023: 413.76M JPYOperating income, FY2024: 418.51M JPYOperating income, FY2025: 202.66M JPYNet income, FY2021: 133.73M JPYNet income, FY2022: 198.03M JPYNet income, FY2023: 310.98M JPYNet income, FY2024: 385.8M JPYNet income, FY2025: 155.92M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.78B JPY. Revenue FY2022 2.09B JPY. Revenue FY2023 2.48B JPY. Revenue FY2024 2.68B JPY. Revenue FY2025 2.81B JPY. Operating income FY2021 226.95M JPY. Operating income FY2022 297.56M JPY. Operating income FY2023 413.76M JPY. Operating income FY2024 418.51M JPY. Operating income FY2025 202.66M JPY. Net income FY2021 133.73M JPY. Net income FY2022 198.03M JPY. Net income FY2023 310.98M JPY. Net income FY2024 385.8M JPY. Net income FY2025 155.92M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue2.81B JPY2.68B JPY2.48B JPY2.09B JPY1.78B JPY
Cost of goods sold1.1B JPY987.09M JPY905.31M JPY755.45M JPY670.69M JPY
Gross profit1.71B JPY1.69B JPY1.58B JPY1.34B JPY1.11B JPY
Research and development—18.54M JPY11.42M JPY9M JPY9M JPY
Selling, general, and administrative1.51B JPY1.27B JPY1.14B JPY1.03B JPY875M JPY
Operating expenses1.51B JPY1.27B JPY1.16B JPY1.04B JPY884.31M JPY
Interest income20.69M JPY10.06M JPY3.53M JPY1.87M JPY588K JPY
Interest expense5.45M JPY1.2M JPY———
Depreciation and amortization156.76M JPY128.28M JPY120.59M JPY104.93M JPY96.91M JPY
Operating income202.66M JPY418.51M JPY413.76M JPY297.56M JPY226.95M JPY
Net income155.92M JPY385.8M JPY310.98M JPY198.03M JPY133.73M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
3.57

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates9.796.793.790.8Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 12, 2024: actual 9.13, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 13, 2025: actual 6.64, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 13, 2025: actual 4.49, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual 4.24, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 4.14, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 6.12, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 0.94, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 6, 2026: actual 3.57, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates787.28M727.76M668.24M608.72MQ1 '25MissQ2 '25MissQ3 '25MetQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 13, 2025: actual 667M JPY, estimate 757M JPY, surprise -11.89%, Miss. Q2 2025, reported May 13, 2025: actual 639M JPY, estimate 700M JPY, surprise -8.71%, Miss. Q3 2025, reported Aug 7, 2025: actual 700M JPY, estimate 700M JPY, surprise 0.00%, Met estimate. Q4 2025, reported Nov 12, 2025: actual 715M JPY, estimate 730M JPY, surprise -2.05%, Miss. Q1 2026, reported Feb 12, 2026: actual 729M JPY, estimate 735M JPY, surprise -0.82%, Miss. Q2 2026, reported May 13, 2026: actual 667M JPY, estimate 726M JPY, surprise -8.13%, Miss. Q3 2026, reported Aug 6, 2026: actual 722M JPY, estimate 730M JPY, surprise -1.10%, Miss. Q4 2026, reported Nov 10, 2026: actual —, estimate 740M JPY, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Dividend

Ex-dividend Sep 27, 2024

¥25.00

Special

Record Sep 30, 2024 · Payment Nov 29, 2024

7096.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 7096.T

research.disclaimer